Paxman AB Company Top Insiders
| PXMBF Stock | USD 3.50 0.00 0.00% |
Paxman AB employs about 76 people. The company is managed by 10 executives with a total tenure of roughly 178 years, averaging almost 17.0 years of service per executive, having 7.6 employees per reported executive. Examination of Paxman AB's management performance can provide insight into the company performance.
| Patrick Burke Insider Head Operations |
| Emma Thornhill Insider Head Fin |
Paxman |
Paxman AB Management Team Effectiveness
The company has return on total asset (ROA) of (0.0412) % which means that it has lost $0.0412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0254) %, meaning that it generated substantial loss on money invested by shareholders. Paxman AB's management efficiency ratios could be used to measure how well Paxman AB manages its routine affairs as well as how well it operates its assets and liabilities.Paxman AB owns a total of 19.01 Million outstanding shares. Paxman AB holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.44 pct. of Paxman AB outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Paxman AB in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Paxman AB, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Paxman AB Workforce Comparison
Paxman AB is considered to be number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is at this time estimated at about 4,718. Paxman AB claims roughly 76.0 in number of employees contributing just under 2% to all equities under Medical Devices industry.
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Paxman AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Paxman AB Price Series Summation is a cross summation of Paxman AB price series and its benchmark/peer.
Paxman AB Notable Stakeholders
A Paxman AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Paxman AB often face trade-offs trying to please all of them. Paxman AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Paxman AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Patrick Burke | Head Operations | Profile | |
| Emma Thornhill | Head Fin | Profile | |
| Emelie Gustafsson | Chief Officer | Profile | |
| Claire Paxman | Director Initiatives | Profile | |
| Anna Parker | Head Sales | Profile | |
| Liza Hirst | EA HR | Profile | |
| Stuart Rowling | Head Sales | Profile | |
| Richard Paxman | CEO Director | Profile | |
| Susy Brown | Head Marketing | Profile | |
| Alexandra Sheldrake | Head Affairs | Profile |
About Paxman AB Management Performance
The success or failure of an entity such as Paxman AB often depends on how effective the management is. Paxman AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Paxman management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Paxman management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Paxman AB , together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. The company was founded in 1996 and is based in Karlshamn, Sweden. Paxman Ab is traded on OTC Exchange in the United States.
Paxman AB Workforce Analysis
Traditionally, organizations such as Paxman AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Paxman AB within its industry.Paxman AB Manpower Efficiency
Return on Paxman AB Manpower
| Revenue Per Employee | 1.3M | |
| Revenue Per Executive | 9.6M | |
| Net Loss Per Employee | 168.1K | |
| Net Loss Per Executive | 1.3M |
Complementary Tools for Paxman Pink Sheet analysis
When running Paxman AB's price analysis, check to measure Paxman AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paxman AB is operating at the current time. Most of Paxman AB's value examination focuses on studying past and present price action to predict the probability of Paxman AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paxman AB's price. Additionally, you may evaluate how the addition of Paxman AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |